Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial
- PMID: 22818076
- PMCID: PMC3416917
- DOI: 10.1016/j.jacc.2012.05.022
Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial
Abstract
Objectives: We hypothesized that human atrial fibrillation (AF) may be sustained by localized sources (electrical rotors and focal impulses), whose elimination (focal impulse and rotor modulation [FIRM]) may improve outcome from AF ablation.
Background: Catheter ablation for AF is a promising therapy, whose success is limited in part by uncertainty in the mechanisms that sustain AF. We developed a computational approach to map whether AF is sustained by several meandering waves (the prevailing hypothesis) or localized sources, then prospectively tested whether targeting patient-specific mechanisms revealed by mapping would improve AF ablation outcome.
Methods: We recruited 92 subjects during 107 consecutive ablation procedures for paroxysmal or persistent (72%) AF. Cases were prospectively treated, in a 2-arm 1:2 design, by ablation at sources (FIRM-guided) followed by conventional ablation (n = 36), or conventional ablation alone (n = 71; FIRM-blinded).
Results: Localized rotors or focal impulses were detected in 98 (97%) of 101 cases with sustained AF, each exhibiting 2.1 ± 1.0 sources. The acute endpoint (AF termination or consistent slowing) was achieved in 86% of FIRM-guided cases versus 20% of FIRM-blinded cases (p < 0.001). FIRM ablation alone at the primary source terminated AF in a median 2.5 min (interquartile range: 1.0 to 3.1 min). Total ablation time did not differ between groups (57.8 ± 22.8 min vs. 52.1 ± 17.8 min, p = 0.16). During a median 273 days (interquartile range: 132 to 681 days) after a single procedure, FIRM-guided cases had higher freedom from AF (82.4% vs. 44.9%; p < 0.001) after a single procedure than FIRM-blinded cases with rigorous, often implanted, electrocardiography monitoring. Adverse events did not differ between groups.
Conclusions: Localized electrical rotors and focal impulse sources are prevalent sustaining mechanisms for human AF. FIRM ablation at patient-specific sources acutely terminated or slowed AF, and improved outcome. These results offer a novel mechanistic framework and treatment paradigm for AF. (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation [CONFIRM]; NCT01008722).
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Comment in
-
A FIRM grip on atrial fibrillation.J Am Coll Cardiol. 2012 Aug 14;60(7):637-8. doi: 10.1016/j.jacc.2012.06.009. Epub 2012 Jul 18. J Am Coll Cardiol. 2012. PMID: 22818075 No abstract available.
-
Atrial fibrillation: Electrophysiologists eagerly await independent CONFIRMation of improved method for ablation.Nat Rev Cardiol. 2012 Sep;9(9):491. doi: 10.1038/nrcardio.2012.116. Epub 2012 Aug 7. Nat Rev Cardiol. 2012. PMID: 22869281 No abstract available.
Similar articles
-
Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation).J Am Coll Cardiol. 2014 May 6;63(17):1761-8. doi: 10.1016/j.jacc.2014.02.543. Epub 2014 Mar 13. J Am Coll Cardiol. 2014. PMID: 24632280 Free PMC article. Clinical Trial.
-
Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation).J Am Coll Cardiol. 2013 Jul 9;62(2):138-147. doi: 10.1016/j.jacc.2013.03.021. Epub 2013 Apr 3. J Am Coll Cardiol. 2013. PMID: 23563126 Free PMC article. Clinical Trial.
-
Non-invasive identification of stable rotors and focal sources for human atrial fibrillation: mechanistic classification of atrial fibrillation from the electrocardiogram.Europace. 2013 Sep;15(9):1249-58. doi: 10.1093/europace/eut038. Epub 2013 Feb 28. Europace. 2013. PMID: 23449925 Free PMC article.
-
Mapping and ablating stable sources for atrial fibrillation: summary of the literature on Focal Impulse and Rotor Modulation (FIRM).J Interv Card Electrophysiol. 2014 Sep;40(3):237-44. doi: 10.1007/s10840-014-9889-8. Epub 2014 Mar 20. J Interv Card Electrophysiol. 2014. PMID: 24647673 Review.
-
Rotors as drivers of atrial fibrillation and targets for ablation.Curr Cardiol Rep. 2014 Aug;16(8):509. doi: 10.1007/s11886-014-0509-0. Curr Cardiol Rep. 2014. PMID: 24950671 Free PMC article. Review.
Cited by
-
Catheter ablation for non-paroxysmal atrial fibrillation. A review.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024 Mar;168(1):1-14. doi: 10.5507/bp.2023.053. Epub 2024 Jan 15. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024. PMID: 38230517 Review.
-
Currently approved imaging modalities of atrial fibrillation drivers: Are they in agreement?HeartRhythm Case Rep. 2023 Aug 9;9(10):755-758. doi: 10.1016/j.hrcr.2023.07.022. eCollection 2023 Oct. HeartRhythm Case Rep. 2023. PMID: 38047190 Free PMC article. No abstract available.
-
Catheter Ablation With Morphologic Repetitiveness Mapping for Persistent Atrial Fibrillation.JAMA Netw Open. 2023 Nov 1;6(11):e2344535. doi: 10.1001/jamanetworkopen.2023.44535. JAMA Netw Open. 2023. PMID: 37991761 Free PMC article. Clinical Trial.
-
Overcoming Uncertainties in Electrogram-Based Atrial Fibrillation Mapping: A Review.Cardiovasc Eng Technol. 2024 Feb;15(1):52-64. doi: 10.1007/s13239-023-00696-w. Epub 2023 Nov 14. Cardiovasc Eng Technol. 2024. PMID: 37962813 Review.
-
Electrographic flow mapping of persistent atrial fibrillation: intra- and inter-procedure reproducibility in the absence of 'ground truth'.Europace. 2023 Nov 2;25(11):euad308. doi: 10.1093/europace/euad308. Europace. 2023. PMID: 37956309 Free PMC article.
References
-
- Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–125. - PubMed
-
- Haissaguerre M, Jais P, Shah DC, et al. Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins. N Engl J Med. 1998;339:659–666. - PubMed
-
- Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol. 2012;33:171–257. - PubMed
-
- Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial. JAMA. 2005;293:2634–2640. - PubMed
-
- Oral H, Pappone C, Chugh A, et al. Circumferential Pulmonary-Vein A blation for Chronic Atrial Fibrillation. N Engl J Med. 2006;354:934–941. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
